These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


156 related items for PubMed ID: 9859690

  • 21. Is a central action of acute antimigraine drugs essential?
    Goadsby PJ.
    Cephalalgia; 1997 Jun; 17 Suppl 17():10-1. PubMed ID: 9218879
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Treatment of childhood migraine attacks with oral zolmitriptan and ibuprofen.
    Evers S, Rahmann A, Kraemer C, Kurlemann G, Debus O, Husstedt IW, Frese A.
    Neurology; 2006 Aug 08; 67(3):497-9. PubMed ID: 16775229
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Oral zolmitriptan (Zomig) in the treatment of migraine crisis].
    Regli F, Nater B.
    Rev Med Suisse Romande; 2000 Jan 08; 120(1):81-3. PubMed ID: 10705797
    [No Abstract] [Full Text] [Related]

  • 33. Zolmitriptan: new product. Similar to sumatriptan.
    Prescrire Int; 1999 Apr 08; 8(40):41-3. PubMed ID: 10848058
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Symptomatic treatment of migraine with zolmitriptan: experience with 82 patients].
    Pascual J, Navarro A, Caminero AB, Jurado C, Díaz-Insa S, Huerta M.
    Neurologia; 2006 May 08; 21(4):188-91. PubMed ID: 16832773
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Inhibition of the trigemino-vascular system with 5-HT1D agonist drugs: selectively targeting additional sites of action.
    Martin GR.
    Eur Neurol; 1996 May 08; 36 Suppl 2():13-8. PubMed ID: 8791027
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Efficacy of 5HT in migraine.
    Buzzi MG.
    Cephalalgia; 1999 Sep 08; 19(7):625-6. PubMed ID: 10524654
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.